Alnylam-ISIS Venture Prices IPO – Analyst Blog

By | October 5, 2012
0 Comment

Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals ( ALNY ) and Isis Pharmaceuticals, Inc. ( ISIS ), recently announced the pricing of its initial public offering

Originally posted here:
Alnylam-ISIS Venture Prices IPO – Analyst Blog

Related posts:

  1. Alnylam-Tekmira Settle Up – Analyst Blog
  2. Isis Pharma, AstraZeneca Ink Deal – Analyst Blog
  3. DRE Prices 36M Stock Offering – Analyst Blog
  4. Gulfport Energy Prices Offering of 11 Million Shares; Down 2% in Pre-Market